+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Poultry and Porcine Vaccines Market (2022-2027) by Disease, Technology, Dosage Form, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 173 Pages
  • May 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5635766

Influenza A viruses are important pathogens with a very broad host spectrum including domestic poultry and swine

The Global Poultry and Porcine Vaccines Market is estimated to be USD 1.89 Bn in 2022 and is expected to reach USD 2.74 Bn by 2027, growing at a CAGR of 7.7%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Poultry and Porcine Vaccines Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Poultry and Porcine Vaccines Market is segmented based on Disease, Technology, Dosage Form, and Geography.
  • By Disease, the market is classified into Infectious Bronchitis, Marek’s Disease, and New Castle Disease.
  • By Technology, the market is classified into Inactivated, Live Attenuated Vaccines, Recombinant, and Toxoid.
  • By Dosage Form, the market is classified into Duct, Freeze Dried Vaccines, and Liquid.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Biovac, Boehringer Ingelheim International, CAVAC, Ceva Santé Animale, Chengdu Kanghua Biological Products, China Animal Husbandry Industry, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Poultry and Porcine Vaccines Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. The analyst analyses the using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Poultry and Porcine Vaccines Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Poultry and Porcine Vaccines Market

What is the estimated value of the Global Poultry and Porcine Vaccines Market?

The Global Poultry and Porcine Vaccines Market was estimated to be valued at $1.89 Billion in 2022.

What is the growth rate of the Global Poultry and Porcine Vaccines Market?

The growth rate of the Global Poultry and Porcine Vaccines Market is 7.7%, with an estimated value of $2.74 Billion by 2027.

What is the forecasted size of the Global Poultry and Porcine Vaccines Market?

The Global Poultry and Porcine Vaccines Market is estimated to be worth $2.74 Billion by 2027.

Who are the key companies in the Global Poultry and Porcine Vaccines Market?

Key companies in the Global Poultry and Porcine Vaccines Market include Biovac, Boehringer Ingelheim International, CAVAC, Ceva Santé Animale, Chengdu Kanghua Biological Products, China Animal Husbandry Industry, Dechra Pharmaceuticals DHN, Elanco Animal Health, Harbin Veterinary Research Institute and Hester Biosciences.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Incidence of Animal Diseases
4.1.2 Surge in Awareness on Animal Vaccination Globally
4.1.3 Growing Need to Increase Poultry Population With Demand for Animal Protein Worldwide
4.2 Restraints
4.2.1 Availability of Counterfeit Medicine
4.3 Opportunities
4.3.1 Technological Advancements for Vaccine Manufacturing
4.3.2 Ongoing Aim to Increase Food Safety Coupled with Favorable Government Initiatives
4.4 Challenges
4.4.1 Strict Regulatory Approval and Compliance Concerns
4.4.2 Increasing Cost of Veterinary Testing and Services
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Poultry and Porcine Vaccines Market, By Disease
6.1 Introduction
6.2 Infectious Bronchitis
6.3 Marek’s Disease
6.4 New Castle Disease
7 Global Poultry and Porcine Vaccines Market, By Technology
7.1 Introduction
7.2 Inactivated
7.3 Live Attenuated Vaccines
7.4 Recombinant
7.5 Toxoid
8 Global Poultry and Porcine Vaccines Market, By Dosage Form
8.1 Introduction
8.2 Duct
8.3 Freeze Dried Vaccines
8.4 Liquid
9 Americas’ Poultry and Porcine Vaccines Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe’s Poultry and Porcine Vaccines Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe
11 Middle East and Africa’s Poultry and Porcine Vaccines Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA
12 APAC’s Poultry and Porcine Vaccines Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 Biovac
14.2 Boehringer Ingelheim International
14.3 CAVAC
14.4 Ceva Santé Animale
14.5 Chengdu Kanghua Biological Products
14.6 China Animal Husbandry Industry
14.7 Dechra Pharmaceuticals DHN
14.8 Elanco Animal Health
14.9 Harbin Veterinary Research Institute
14.10 Hester Biosciences
14.11 Hipra Laboratories
14.12 Indovax Private
14.13 Merck & Co.
14.14 MSD
14.15 Phibro Animal Health
14.16 Proteon Pharmaceuticals
14.17 Ringpu(Tianjin)Bio-Pharmacy
14.18 Venkys
14.19 Virbac
14.20 Zoetis
15 Appendix
15.1 Questionnaire

Companies Mentioned

  • Biovac
  • Boehringer Ingelheim International
  • Ceva Santé Animale
  • Chengdu Kanghua Biological Products
  • China Animal Husbandry Industry
  • Dechra Pharmaceuticals DHN
  • Elanco Animal Health
  • Harbin Veterinary Research Institute
  • Hester Biosciences
  • Hipra Laboratories
  • Indovax Private
  • Merck & Co.
  • MSD
  • Phibro Animal Health
  • Proteon Pharmaceuticals
  • Ringpu(Tianjin)Bio-Pharmacy
  • Venkys
  • Virbac
  • Zoetis